Chronic Eosinophilic Leukemia, NOS

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Organization(s) Biomarker(s) Cancer type Therapy(ies)
EMA (1) FDA (1) FIP1L1::PDGFRA Chronic Eosinophilic Leukemia, NOS Imatinib